Correlation Between Enfusion and DocuSign

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enfusion and DocuSign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and DocuSign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and DocuSign, you can compare the effects of market volatilities on Enfusion and DocuSign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of DocuSign. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and DocuSign.

Diversification Opportunities for Enfusion and DocuSign

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Enfusion and DocuSign is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and DocuSign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DocuSign and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with DocuSign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DocuSign has no effect on the direction of Enfusion i.e., Enfusion and DocuSign go up and down completely randomly.

Pair Corralation between Enfusion and DocuSign

Given the investment horizon of 90 days Enfusion is expected to generate 2.0 times less return on investment than DocuSign. But when comparing it to its historical volatility, Enfusion is 4.27 times less risky than DocuSign. It trades about 0.3 of its potential returns per unit of risk. DocuSign is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  8,122  in DocuSign on September 12, 2024 and sell it today you would earn a total of  1,463  from holding DocuSign or generate 18.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Enfusion  vs.  DocuSign

 Performance 
       Timeline  
Enfusion 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.
DocuSign 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in DocuSign are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental indicators, DocuSign unveiled solid returns over the last few months and may actually be approaching a breakup point.

Enfusion and DocuSign Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enfusion and DocuSign

The main advantage of trading using opposite Enfusion and DocuSign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, DocuSign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocuSign will offset losses from the drop in DocuSign's long position.
The idea behind Enfusion and DocuSign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets